Santa Cruz Biotechnology

AM-630-4 | Santa Cruz Biotechnology

CB2 Inhibitor, AM-630 is a selective CB2 receptor antagonist that binds to CB1 and CB2 receptors

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.